HUMAN INTRAVENOUS PHARMACOKINETICS AND ABSOLUTE ORAL BIOAVAILABILITY OF CEFATRIZINE

被引:32
作者
PFEFFER, M [1 ]
GAVER, RC [1 ]
XIMENEZ, J [1 ]
机构
[1] LABS TERAP BRISTOL SA,SAO PAULO,BRAZIL
关键词
D O I
10.1128/AAC.24.6.915
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:915 / 920
页数:6
相关论文
共 16 条
[1]  
Diem K., 1962, DOCUMENTA GEIGY SCI, P538
[2]  
DUDUBOIS, 1916, ARCH INTERN MED, V17, P863
[3]  
GAVER RC, 1980, DRUG METAB DISPOS, V8, P157
[4]  
Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409
[5]  
KIMURA T, 1983, J PHARMACOBIO-DYNAM, V6, P246
[6]   BL-S640 640, A CEPHALOSPORIN WITH A BROAD-SPECTRUM OF ANTIBACTERIAL ACTIVITY - PROPERTIES INVITRO [J].
LEITNER, F ;
BUCK, RE ;
MISIEK, M ;
PURSIANO, TA ;
PRICE, KE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 7 (03) :298-305
[7]  
Matsuzaki M, 1976, Jpn J Antibiot, V29, P90
[8]   CEFATRIZINE ACTIVITY COMPARED WITH THAT OF OTHER CEPHALOSPORINS [J].
NEU, HC ;
FU, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (02) :209-212
[9]   THE APPLICATION OF STATISTICAL MOMENT THEORY TO THE EVALUATION OF INVIVO DISSOLUTION TIME AND ABSORPTION TIME [J].
RIEGELMAN, S ;
COLLIER, P .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :509-534
[10]  
RIPA S, 1979, FARMACO-ED SCI, V34, P1055